Peritoneal mesothelioma.

Current treatment options in oncology

Volumn 1, Issue 4, 2000, Pages 303-312

  Taub, R N ^a   Keohan, M L ^a   Chabot, J C ^a   Fountain, K S ^a   Plitsas, M ^a  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

CLINICAL TRIAL; DIET THERAPY; HUMAN; MESOTHELIOMA; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PERITONEUM TUMOR; RADIOTHERAPY; REVIEW; SURVIVAL RATE;

ANTINEOPLASTIC AGENTS; CLINICAL TRIALS; COMBINED MODALITY THERAPY; DIET THERAPY; HUMANS; MESOTHELIOMA; PERITONEAL NEOPLASMS; RADIOTHERAPY; SURVIVAL RATE;

EID: 0034308658     PISSN: 15272729     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11864-000-0046-5     Document Type: Review

References (44)